Filing Details
- Accession Number:
- 0001181431-10-001603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-06 12:00:00
- Reporting Period:
- 2010-01-04
- Filing Date:
- 2010-01-06
- Accepted Time:
- 2010-01-06 12:01:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224111 | F Richard Walsh | 940 Winter Street Waltham MA 02451 | Svp & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-01-04 | 300,000 | $19.83 | 492,438 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-01-04 | 300,000 | $20.37 | 192,438 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | NQ Stock Option (right to buy) | Acquisiton | 2010-01-04 | 300,000 | $0.00 | 300,000 | $19.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 300,000 | 2010-01-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,745 | Indirect | 401(K) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $20.28 to $20.75. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The Reporting Person's indirect holdings include shares acquired pursuant to reinvestment of dividends relating to the Reporting Person's 401(K) account.
Billionaire Hedge Funds
